“Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations With Various Genetic Variants”. Precision Medicine Communications, vol. 2, no. 1, June 2022, pp. 59-78, https://doi.org/10.55627/pmc.002.001.0053.